Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04580719
Other study ID # PO19076
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 4, 2019
Est. completion date December 31, 2019

Study information

Verified date June 2020
Source CHU de Reims
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Intimate protections are designed to absorb menstrual flow during menstruation. A woman will use an average of 6,000 intimate protections during her lifetime. Intimate protections are classified into two categories: internal intimate protections including tampon, menstrual cup, menstrual sponge, and external intimate protections including disposable or washable sanitary pads, panty liner, menstrual panty. The choice and use of a type of intimate protection will depend on multiple factors specific to each woman. Due to a growing media interest in this area, women have become extremely critical and suspicious of these devices, particularly about the Toxic Shock Syndrome, attributed to the use of tampon in women previously colonized vaginally by strain of toxin-producing Staphylococcus aureus (Toxic shock syndrome toxin-1 (TSST-1)). Similarly, chemical residues have been found in sanitary napkins.

As a result, women's expectations have changed and there is a greater demand for transparency with regard to intimate protection of their composition and their potential health risks. Women want more and more alternative to conventional intimate protections in today's climate of increasing environmental awareness.

It is a cross-sectional, observational, prospective, unicentric inclusion study (CHU de Reims). The primary objective is to describe women's intimate protection practices. The secondary objectives are to study the determinants of women's choice for intimate protection, to describe women's knowledge of the potential risks of these intimate protections. and women's information sources on intimate protections. Finally describe the expectations of women in terms of intimate protections. The results are intended to give a photograph of the practices and knowledge of women consulting in the Obstetrics and Gynecology Department of the University Hospital of Reims concerning intimate protections.

Patients aged 18 to 50, presenting menstrual cycles, consulting in the obstetrics and gynecology department of the University Hospital of Reims whatever the reason for consultation can participate in the study after signing the consent of no opposition. Participation in the study will not change the patient's medical management. Participation in the study will result in the completion of a questionnaire concerning intimate protections. The filling time of the questionnaire is estimated at 10 minutes.

This subject is evolving with a growing awareness of women on the management of their rules, the products used, their potential risks and the environment. This study will allow us to see if women are really informed and feel concerned by these changes. And in the end, find out if they are ready to turn to intimate protections called "alternatives" The results will give us a vision of the expectations of our patients in this area as well as the information received, and thus allow us to publish an information guide and good practices of the intimate protections available in the waiting rooms of our consultations.

In addition, this study will allow health professionals to discuss this subject more easily and easily with their patients.


Recruitment information / eligibility

Status Completed
Enrollment 1153
Est. completion date December 31, 2019
Est. primary completion date December 31, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility inclusion criteria :

- aged 18 to 50

- presenting menstrual cycles

exclusion criteria :

- not signing the consent of no opposition

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Damien JOLLY Reims

Sponsors (1)

Lead Sponsor Collaborator
CHU de Reims

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Use of tampon Number of patients using tampon as hygienic protection Day 0
Primary Use of menstrual cup menstrual sponge Number of patients using menstrual cup as hygienic protection Day 0
Primary Use of menstrual sponge Number of patients using menstrual sponge as hygienic protection Day 0
Primary Use of disposable sanitary pads Number of patients using disposable sanitary pads as hygienic protection Day 0
Primary Use of washable sanitary pads Number of patients using washable sanitary pads as hygienic protection Day 0
Primary Use of panty liner Number of patients using panty liner as hygienic protection Day 0
Primary Use of menstrual panty Number of patients using menstrual panty as hygienic protection Day 0
See also
  Status Clinical Trial Phase
Recruiting NCT04870216 - Evaluation of Practices, Knowledge and Expectations of Medical Students for Intimate Protection